Skip to main content

Table 3 Relationship between Karnofsky's performance status (KPS) score and survival estimate

From: Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer

KPS score quartile Median survival (in months)
10–30 2.1
40–50 4.5
60 6.7
70–90 17.1
  1. (Hazard ratio: 0.79; 95% Confidence Interval: 0.62–0.85, p value < 0.0001)